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Increased Periodontal Attachment Loss 
in Patients With Systemic Sclerosis 
Nicole Pischon, * Daniela Hoedke, * Sven Kurth, * Paul Lee,* Henrik Dommisch, *t 
Astrid Steinbrecher, r Tobias Pischon, r Gerd R. Burmester,§ Frank Buttgereit,§ 
Jacqueline Detert,§ and Gabriela Riemekastenll~ 
Background: Patients with inflammatory rheumatic dis-
eases and periodontitis share common pathogenetic charac-
teristics, such as proinflammatory traits causative for tissue 
degradation and loss of function. The aim of the present 
case control study is to investigate the association between 
systemic sclerosis (SSc) and periodontitis. 
Methods: The association between SSc and periodontitis 
was examined in 58 SSc patients and 52 control patients, 
matched for age and sex. The periodontal examination included 
periodontal attachment loss (AL}, probing depth, bleeding on 
probing, plaque index (PI), and gingival index (GI). Potential 
risk factors of periodontitis were assessed through patients' 
questionnaires. 
Results: In unadjusted analyses, patients with SSc had a sig-
nificant 0.61 mm higher AL (95% confidence interval [CI] 
0.24 to 0.97; P == 0.002) when compared with controls. In a 
stepwise logistic regression, including SSc status, age, sex, 
education, smoking, alcohol consumption, and body mass in-
dex, only SSc status, age, and sex remained significantly asso-
ciated with periodontitis. Adjusted for age and sex, patients 
with SSc had a 0.52 mm higher AL compared with controls 
(95% Cl 0.16 to 0.88; P== 0.005). The strength of the associa-
tion of SSc with AL remained statistically significant after addi-
tional adjustment for PI (0.44 mm; 95% Cl 0.02 to 0.86; P == 
0.04) or GI (0.61 mm; 95% CI 0.24 to 0.97; P== 0.001). 
Conclusions: This study demonstrates higher AL in patients 
with SSc, which remained significant after adjustment. The study 
indicates a possible relationship between SSc and periodontitis. 
J Periodontol2016;87:763-771. 
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Periodontitis is a common inflam-matory disease in humans, affecting 46% of adults in the United States, 
with 8.9% having severe periodontitis. 1 
Periodontitis is induced by an anaerobic 
Gram-negative bacterial biofilm on the 
dental root surface and is characterized 
by dysregulation of the hast immune re-
sponse.2 Immune cell activation by bac-
terial pathogens initiates the production 
of )arge amounts of inflammatory media-
tors, such as tumor necrosis factor a, 
which further stimulates the release of 
other mediators, including proteolytic en-
zymes and additional dysbiosis and in-
flammation, resulting in soft tissue and 
hard tissue periodontal breakdown and 
eventually in tooth mobility and lass. 3 The 
degree of inflammation varies among in-
dividuals with periodontitis independently 
of the degree of bacterial infection, sug-
gesting that alterations of the immune 
function may contribute substantially to 
the extent of periodontal disease.4 
In recent years, it has become ap-
parent that patients with inflammatory 
rheumatic diseases and periodontitis 
share common pathogenetic charac-
teristics, such as proinflammatory traits 
causative for tissue degradation and 
lass of function. 5 ·8 Evidence from epi-
demiologic studies suggests that peri-
odontal disease is more common in 
patients with inflammatory rheumatic dis-
eases, such as in patients with rheumatoid 
arthritis.4 ·9 · 11 Intervention studies indi-
cate a causal relationship by showing that 
doi: 10.!902/jop.2016.150475 
763 
Kopie von subito e.V., geliefert für Max-Delbrück-Centrum / Zentralbibliothek (SLS02X00837)
periodontal therapy reduces rheumatic disease activity 
and severity_9,12-14 
Systemic sderosis (SSc) is a chronic systemic 
disease of unknown etiology, characterized by skin 
sderosis, vasculopathy, and complications of inner 
organs, such as in the Jung, heart, kidney, and gas-
t · t · 1 15 16 rom estma tract. · The prevalence varies from five 
to 30 individuals per 100,000, with a higher preva-
lence among females compared with mal es. 17· 18 Only 
a limited number of studies have examined the overall 
oral status and in particular the periodontal status in 
patients with SSc. 19·23 Only two recent studies in-
vestigated the association between SSc and periodontal 
disease, indicating a positive correlation. 22.23 SSc has 
been reported to be associated with an increased risk of 
salivary hypofunction, dental caries, and abnormalities 
in periodontal microcirculation. 19·21 ·24 lt is unknown 
whether a Iimitation attributable to SSc, such as pro-
gressive limited mouth opening, impedes individual 
and professional oral hygiene measures, making pa-
tients with SSc more susceptible to plaque accumu-
lation and, consequently, to inflammatory periodontal 
disease and SSc. 23 However, it remains an open question 
whether major risk factors of periodontitis, such as 
poor oral hygiene, may account for the association. 
Therefore, the present case control study aims to in-
vestigate the association between SSc and periodon-
titis and whether potential risk factors of periodontal 
diseases (e.g., poor oral hygiene, smoking, low edu-
cation, daily alcohol consumption, and high body 
mass index [BMI]) may account for this association. 
MATERIALS AND METHODS 
Study Population 
From 2008 to 2011, a total of 110 patients (23 mal es 
and 87 females, aged 19 to 75 years; mean age: 53.7 
years) were included and assessed in the present case 
control study: 58 patients with SSc and 52 control 
patients without SSc frequency matched for age and 
sex as a control group. Patients with SSc were recruited 
from individuals with prevalent SSc, who attended the 
Department of Rheumatology and Clinical Immunol-
ogy, Charite-universitätsmedizin Berlin, Berlin, Ger-
many. Control patients were recruited from patients 
attending the general dental Outpatient office. Patients 
with SSc fulfilled classifications according to the re-
cently revised European League Against Rheuma-
tism/American College of Rheumatology criteria.25 
Based on the current recommendations of the German 
network for SSc, four types of the disease have been 
distinguished with regards to clinical outcomes: 1) 
limited SSc; 2) diffuse SSc; 3) overlap syndrome; and 4) 
sclerosis sine scleroderrna. 26 Exdusion criteria for cases 
and controls induded the following: 1) <12 teeth; 2) 
a history of periodontal therapy or use of antibiotics 
during the past 6 months before the examination; and 3) 
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pregnancy or lactation. The study protocol was de-
veloped in full accordance to the dedaration of Helsinki 
and was approved by the ethics committee of the 
Charite-Universitätsmedizin Berlin (EA 1/244/08). 
All study patients provided written informed consent. 
Assessment of Clinical Rheumatologie 
Parameters 
Disease activity in patients with SSc was investi-
gated by the activity index according to European 
Sderoderma Study Group and Research.27 The in-
volvement of the Jung was assessed by measuring the 
diffusing capacity per single breath and the forced 
expiratory vital capacity of the lung. Thickness of the 
skin was assessed by the modified Rodnan skin 
score.28 
Labaratory Examinations 
Blood plasma was collected from patients with SSc 
and analyzed for antinuclear antibodies and anti-RNA 
polymerase (SCL70) antibody by routine Iabaratory 
testing.* 
Intraoral Examination 
Oral examinations of all study participants were per-
formed by SK, who was trained by NP, a German 
Academy of Periodontology specialist for periodontol-
ogy. An intraexaminer calibration was not perforrned. A 
manual periodontal probe** was used, and the readings 
were recorded to the nearest 1 mm. All periodontal 
measurements were assessed at four sites of each tooth 
(mesio-buccal, disto-buccal, mesio-lingual, and disto-
lingual), as described previously.4·9·11 Plaque accu-
mulation as a measurement of oral hygiene status was 
recorded with a plaque index (PI) according to Silness 
and Löe.29 Gingival index (GI) to measure the extent of 
inflammatory gingivitis was evaluated according to 
Löe.30 PI and GI were calculated as intra-individual 
means from four sites per tooth of degrees 0 to 3. 
Probing depth (PD) was defined as the distance from 
the free gingival margin to the bottarn of the sulcus or 
periodontal packet. The mean of all sites per indi-
vidual was calculated for additional analysis. Gingival 
recession was defined as the distance from the 
cemento-enamel junction (CEJ) to the free gingival 
margin. Periodontal attachment Ioss (AL) was defined 
as the distance from the CEJ to the bottarn of the 
sulcus or periodontal packet and was calculated as the 
sum of PD and gingival recession measurements. 
Bleeding on probing (BOP) was evaluated dichoto-
mously as bleeding present or absent 10 seconds after 
probing at all sites >3 mm.31 An indexwas calculated 
between 0 (no site with BOP) and 1 (all sites with 
BC:)p), Severity categories of periodontal disease (no, 
mtld, moderate, or severe periodontitis) were assigned 
# Labor Berlin Charite Vivantes, Berlin, Germany. 
** PCP 15, Hu-Friedy, Chicago, IL. 
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according to Eke et al. 32 In addition, the decayed, 
missing, filled teeth index (DMF-T) according to Klein 
and evaluation of the temporamandibular joint (TMJ) 
(pain, crepitation, and Iimitation of movements) was 
recorded.33•34 Because ofthe observational design ofthe 
study, oral radiographs were not routinely performed. 
Assessment of Risk Factors 
Sodademographie characteristics, Iifestyle factors, and 
medical history were assessed by a self-administered 
questionnaire. Anthropometrie data (height and weight) 
were measured. 
Smoking status was classified as never smoker, for-
mer smoker, or current smoker. Alcohol consumption 
was classified based on the reported drinking frequency 
as seldom (less than or equal to once a month), mod-
erately often (twice a month or several times a week), or 
daily (daily or even more frequently). BMI (calculated 
from the body weight in kilograms divided by the square 
of height in meters) was classified as normal weight 
(<25 kg/m2), overweight (25 to <30 kg/m2), or obese 
(~30 kg/m2 ). Educational attainment was classified as 
untrained (none), trained workers, or academic edu-
cation. In addition, the assessment of the medical his-
tory included diseases that are associated with SSc. 
Statistical Analyses 
Power calculation was performed by expecting a dif-
ference in mean AL of 0.1 mm with a standard de-
viation of 1.2 mm between the SSc group and the 
cantrot group. Forty-eight individuals per group were 
examined and given a power of 80% and a Ievel of 
significance of a = 0.05. This was rounded up to 50 
persans per group. 
Frequency distributions, means, and standard de-
viations, as weil as medians and interquartile ranges 
(IQRs), were determined to describe the data. Data 
distributionwas checked graphically. Risk factors and 
dental variables were compared between patients with 
SSc and controls using Student unpaired t test for 
continuous normally distributed variables, Wilcoxon 
test for continuous variables without normal distri-
bution, or the x2 test for categorical variables. The 
association between SSc and periodantat status was 
assessed by linear regression procedures, taking the 
mean AL as continuous dependent variable and dif-
ferent independent variables. In a first step, the as-
sociation of individuals' characteristics with the mean 
AL was assessed using univariate linear regression. In 
addition, the association among different SSc types 
(Iimited SSc, diffuse SSc) with AL was analyzed 
separately. In a second step, a stepwise muitivariable-
adjusted logistic regression was used with SSc as the 
primary independent variable and periodontitis as the 
dependent variable, with additional inclusion of age, 
sex, educational attainment, smoking status, alcohol 
consumption, and BMI into the model. In a third step, 
the final multivariable regression model was addi-
tionally adjusted for PI, GI, or both to estimate to what 
extent adjustment for these potentially intermediate 
variables influence the association between SSc and 
periodontitis. Regression analyses were performed by 
complete case analysis. 
All P values presented are two tailed, and P values 
<0.05 were considered statistically significant. Anal-
yses were performed using statistical software. tt 
RESULTS 
Sociodemographic Characteristics, Lifestyle 
Factors, and Aspects of Medical History of 
lndlviduals With SSc and Controls 
Sodademographie characteristics, Iifestyle factors, 
and aspects of medical history of patients with SSc 
and controls are shown in Table 1. BMI was signifi-
cantly (P= 0.03) higher in control patients (25.3 ± 4.4 
kg/m2 ) compared with patients with SSc (23.5 ± 3.7 
kg/m2). Significant differences among patients with 
SSc and controls were also observed in educational 
attainment (P= 0.02), as weil as alcohol consumption 
(P= 0.02). 
Rheumatologie Parameters 
Clinical parameters and Iabaratory examinations of 
patients with SSc are shown in Table 2. Six patients 
suffered from Hashimoto thyroiditis, three from Graves 
disease, one from Waldenström macroglobulinemia, 
one from multiple myeloma, and one from sarcoidosis. 
Patients with SSc were und er medication with low-dose 
glucocorticoids (62%), cyclophosphamide (31 %), 
iloprost (28%), bosentan (19%), and methotrexate (7%) 
at the time of the investigation. 
Intraoral Examination 
Table 3 showsdental variables in patients with SSc and 
controls. The mean AL was significantly higher in pa-
tients with SSc compared with control patients (4.01 ± 
1.04 versus 3.40 ± 0.89 mm; P= 0.002). However, the 
mean PD was not statistically different between patients 
with SSc compared with the control group (2.99 ± 0.59 
versus 3.16 ± 0.58 (P= 0.11 ). Severity of periodontitis 
was significantly different between the two groups 
(P <0.001 ). Significantly higher plaque accumulation 
was found in patients with SSc (median [IQRj, 0.88 
[0.46 to 1.73] versus 0.35 [0.20 to 0.58]; P <0.001). 
However, a lower GI was measured in patients with 
SSc (median [IQRJ, 0.16 [0.07 to 0.40]) compared 
with cantrot patients (0.49 [0.26 to 0. 73]; P<0.001 ). 
Also, significantly more numbers of patients with 
SSc suffered from TMJ symptoms compared with 
cantrot patients (55 versus 12; P <0.00 1). 
tt SAS v.9.3, SAS Institute, Cary, NC. 
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Table I. 
Sociodemographic Characteristics, Lifestyle Factors, and Medical History of Individuals 
With SSc and Controls 
Chaa:teriS:ics ffi:; (n = 58)* 
Maes 14 (24.1) 
A~ (yea-s), mea1 ± SJ 55.1 ± 12.9 
B:luccii ona ctt ai rrnent 
None 9 (15.5) 
Trainee! worka- 33 (56.9) 
Aca::lemic 14 (24.1) 
MisSng vaue 2 (3.4) 
Snoking stcius 
N eva- snoka- 26 (44.8) 
Forme- snoker 24 (41.4) 
Current snoka- 7 (12.1) 
Mis9ng vaue 1 (1.7) 
Alcot"ol COI'lSlfT'Iption frequency 
Noor low 37 (63.8) 
Moderciety often 12 (20.7) 
Daily 6 (10.3) 
MisSng vaue 3 (5.1) 
Btvll (kg'm2) 
<25 (normal) 40 (69.0) 
::.::25 to <30 (overweig,t) 14 (24.1) 
::.::30 (obese) 3 (52) 
Mis9ng vaue 1 (1.7) 
131\111 (kg'm2), mea1 ± SJ 23.5 ± 3.7 
Hypertension 28 (49.12) 
Dicbetes mellitus 0 (0.0) 
Dy9ipidemia 13 (23.2) 
Coronay hea-t di99CB3 5 (9.6) 
Osteapoross 3 (5.1) 
Controls (n =52)* 
9 (17.3) 
52.1 ± 13.7 
2 (3.9) 
26 (50.0) 
24 (462) 
0 (0) 
31 (59.6) 
11 (212) 
10 (192) 
0 (0.0) 
23 (442) 
25 (48.1) 
4 (7.7) 
0 (0.0) 
23 (442) 
22 (42.3) 
7 (13.5) 
0 (0) 
25.3 ± 4.4 
19 (36.5) 
3 (5.8) 
11 (21.2) 
2 (3.9) 
1 (1.9) 
pt 
0.38 
0.23 
0.02 
o.os 
0.02 
0.02 
0.03 
0.19 
0.11 
0.80 
0.44 
0.62 
• Data are numbers of individuals {percentages) unless stated otherwise. 
t Variables were compared between cases and controls using the X2 test or Fisher exact test (two·tailed) for categorical variables and using Student unpaired 
t test for continuous variables. 
Association of SSc and the lndividuals' 
Characteristics With Periodontitis 
The univariate association of SSc and individuals' 
characteristics with the mean AL is shown in Table 4. 
In univariate logistic regression analysis, patients with 
SSc had a 0.61-mm higher AL (95% confidence in-
tervai [CI] = 0.24 to 0.97; P= 0.002) when compared 
with control patients. According to the SSc types, 
patients with diffuse SSc had a 0.81-mm (95% CI = 
0.39 to 1.22; P <0.001) higher ALand patients with 
limited SSc had a 0.29-mm (95% CI = -0.29 to 0.87; 
P = 0.32) higher AL compared with controi patients. 
766 
Potential risk factors of periodontitis, such as 
higher age, low education, smoking, daily alcohol 
consumption, and increased BMI, were related to AL, 
but only age and education were statistically signif-
icant at the 5% Ievel. 
Next, a stepwise multivariate logistic regression 
with SSc as the primary independentvariable and AL 
as the dependent variable, including age, sex, edu-
cation, smoking, alcohol consumption, and BMI into 
the model, was applied to examine the association of 
SSc with the odds ratio (OR) of periodontitis adjusted 
for potential confounders. 
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Table 2. 
Rheumatologie Characteristics and 
Laboratory Examinations of Patients 
With SSc 
Disa<B3 Cha-aieristics of lndividuas With 
s:t (n =58) 
Tyt>e of 59:: 
Diffuse cuta1e0us 59:: 
Umited cuta'leOUS S9: 
Over~~rome 
9jero9s sine s:leroderrre 
Undifferenticted S9: 
Oisa<B3 durction (5-yea- cctegxies) 
::;5 
>5 to 10 
>10 
Disa<B3 durction (yea-s), mea-1 ± ffi 
n (%)* 
36 (62.1) 
14 (24.1) 
5 (8.6) 
1 (1.7) 
2 (3.5) 
23 (39.7) 
18 (31.0) 
9 (15.5) 
6.2 ± 5.1 
• Data are numbers of individuals (percentages) unless stated otherwise. 
Disease duration data was derived from 50 of 58 patients. 
Only SSc status remained statistically significant 
at the 5% Ievel associated with AL. To examine which 
variables were the next in a multivariable model, a 
was stepwise increased by 1 %. The next variables 
entering into the model after adjusting a to 8% were 
age and sex. Thus, adjusted for age and sex, patients 
with SSc had a 0.52-mm higher AL (95% CI= 0.16 to 
0.88; P = 0.005) compared with controls (Table 5). 
To examine whether oral hygiene as a potentially 
intermediate factor may account for the observed 
association between SSc and periodontitis, the final 
multivariable regression model was additionally ad-
justed for PI, GI, or both (Table 5). The strength of the 
association of SSc with AL remained statistically sig-
nificant after additional adjustment for plaque accu-
mulation (0.44 mm; 95% CI= 0.02 to 0.86; P= 0.04), 
gingival inflammation (0.61 mm; 95% CI= 0.24 to 0.97; 
P= 0.001), or both plaque accumulation and gingival 
inflammation (0.64; 95% CI= 0.20 to 1.08; P= 0.005). 
DISCUSSION 
In the present case control study, a significantly higher 
mean AL was observed in the SSc group compared with 
the control group (4.01 ± 1.04 versus 3.40 ± 0.89; P= 
0.002). This association remained significant indepen-
dent of demographic and Iifestyle characteristics, in-
cluding age, sex, education, smoking status, and alcohol 
consumption. When adjustments for age and sex were 
made, the mean AL did not change substantially 
(0.52 mm; 95% CI= 0.16 to 0.88 mm; P= 0.005). 
Also, AL is considered tobe a measure of the elapsed 
periodontal disease process rather than parameters 
such as PD.35·36 Interestingly, despite the finding of 
higher AL in patients with SSc, clinical parameters, 
including increased PD, BOP, and gingival inflam-
mation, were not significantly increased in patients 
with SSc. Because SSc is often associated with 
impaired mouth opening, personal oral hygiene may 
be limited, as shown in the present study by increased 
plaque accumulation in patients with SSc. Recently, it 
was shown that SSc oral hygiene measures are ben-
eficial for patients with SSc.37 However, in the present 
study, the association between SSc and AL remained 
statistically significant after additional adjustment 
for plaque accumulation, suggesting that poor oral 
hygiene may oniy partially account for the higher 
prevalence of periodontitis among patients with SSc 
and that other parameters among the mediators 
may be responsible for the increased prevalence of 
periodontitis in individuals with SSc. It remains to 
be analyzed whether periodontal therapy affects SSc 
disease activity. 
ln SSc, despite increased plaque accumulation, 
chronic fibrosis and alterations of the gingival micro-
vasculature of the periodontal tissues may be re-
sponsible for greater periodontal breakdown, despite 
less acute periodontal inflammatory signs. A reduced 
number of periodantat capillary loops and reduced 
Ievels of vascular endothelial growth factor expression 
have been found in SSc.21 ·38 Vascular alterations may 
Iimit the angiogenic responsiveness to plaque bacteria 
in periodantat tissues. In the present study, a higher 
number of patients with SSc with higher AL (mean 
AL >4 mm) were under iloprost medication compared 
with patients with SSc with Iower AL (mean AL <4 mm) 
(data not shown). Administration of iloprost indicates 
severe vascuiopathy, which could also affect peri-
odontitis outcome. In addition, tissue fibrosis, charac-
terized by excessive deposition of the extracellular 
matrix, especially fibrous collagen by pathologic fi-
broblasts, is the main characteristic of SSc.39 Affecting 
the skin and many internal organs, fibrosis represents 
a major cause for the high morbidity and mortality in 
SSc.15·16 lnflammation seems to play a major role in 
the pathologic process leading to fibrosis.4° Fibrous 
alterations of the vasculature and surrounding con-
nective tissues may Iead to chronic ischemia and 
impairment of immune cell activation and diapede-
sis.40 lncreased collagen accumulation and collagen 
cross-linkage in SSc impairs overall tissue remod-
eling, specifically in response to bacterial challenge. 
Interestingly, similar to the present findings in pa-
tients with SSc, smokers tend to have reduced clinical 
signs of periodontal inflammation regardless of the 
Ievels of plaque accumulation.41 .42 Tissue fibrosis and 
gingival vasculopathy is responsible for the Sup-
pression of inflammatory clinical signs. 41 .43 Masked 
clinical signs, as seen in patients with SSc, may 
complicate the usual approach to the periodontitis 
767 
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Table 3. 
Dental Characteristics in Patients With SSc and Controls* 
Dentel Chcrcderistics ES: (n =58)* Controls (n = 52)* pt 
AL (mm), mecn ± SJ 4.01 ± 1.04 3.40 ± 0.89 0.002 
0.11 
<0.001 
ffi (mm), mea1 ± SJ 2.99 ± 0.59 3.16 ± 0.58 
~verity cci9!J>ries of periodontitis 
No periodortitis 0 (0) 13 (25.0) 
Mild periodontitis 7 (12.1) 11 (212) 
Moderae periodontitis 22 (37.9} 22 (42.3) 
~vere periodortitis 29 (50.0) 6(11.5) 
A, media1 (IQR) 0.88 (0.46 to 1.73) 0.35 (0.20 to 0.58) <0.001 
<0.001 GI, media1 (IQR) 0.16 (0.07 to 0.40) 0.49 (0.26 to 0.73) 
OOP, media1 (IQR) 0.29 (0.2 to 0.45) 0.41 (0.23 to 0.58) 0.05 
0.32 
020 
N umber of lost teeth, media1 ( IQ R) 5.50 (2.0 to 10.0) 5.0 (0.5 to 8.5) 
N urrber of lost teeth ccieg:Jries 
None 6 (10.3) 13 (25.0) 
1 to 6 28 (48.3) 20 (38.5) 
7 to 12 14 (24.1) 9 (17.3) 
>12 10 (17 2) 10 (192) 
DMF-T index, mea1 ± SJ 17.66 ± 6.00 18.12 ± 6.85 0.71 
<0.001 TMJ9fmptoms, n (%) mea1 ± SJ 55 (94.8) 12 (23.1) 
• Data are numbers of individuals (percentages) unless stated otherwise. 
+Variables were compared between cases and controls using the X2 test for categorical variables, Student unpaired t test for continuous normally distributed 
variables, and Wilcoxon test for continuous variables without normal distribution. 
diagnosis, which must be acknowledged by peri-
odontists and dental hygienists. 
Leung et al. 22 found increased mean PD in patients 
with SSc, but they did not adjust for potential risk 
factors. A recent study by Baron et al. 23 showed an 
adjusted (age, sex, ethnicity, education, and smoking) 
OR of 1.84 (95% Cl= 1.39 to 2.43) for number of 
teeth with periodontitis, defined as PD >3 mm orAL 
~5.5 mm. In the present study, patients with SSc had 
a significantly lower BMI than control patients. Ab-
normal BMI predisposes to inflammatory systemic 
and oral diseases, such as periodontitis.44 Low BMI 
reflects catabolic processes, observed in a variety of 
chronic diseases. Cachexia as a result of chronically 
inflammatory processes has been described as an 
important underlying mechanism in patients with 
SSc. 45 Patients with SSc have specific changes in their 
body composition, and they show signs of malnutri-
tion and reduced energy intake, which reflects disease 
activity and severity. 46-48 
In recent years, evidence has been accumulated 
that periodontitis, similar to other inflammatory dis-
eases including SSc, is not restricted to local tissue 
reaction but may have a systemic effect. 49·50 Both 
diseases are characterized by increased secretion of 
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proinflammatory mediators, which in part may also 
explain the association. Similar to the present findings 
and expressed as the OR instead of AL, the OR of 
periodontitis was increased in patients with other in-
flammatory rheumatic diseases. In previous studies, 
OR of periodontitiswas 6.81 (95% Cl= 1.96 to 23.67) 
in spondyloarthritis ankylosans and 8.05 (95% CI = 
2.93 to 22.09) in rheumatoid arthritis compared with 
control patients. 5• 11 
The present study has strengths and limitations. 
Among the strengths is that the patients with SSc were 
assessed by experienced SSc specialists. Among the 
limitations is the cross-sectional design, which com-
plicates the drawing of causal inferences. Thus, based 
on the study design, whether SSc truly precedes the 
development of periodontitis or vice versa cannot be 
examined. To the best of the authors' knowledge, to 
date, there exist no reports on the prevalence of SSc in 
patients with periodontitis compared with periodontal 
healthy individuals. In addition, a high number of the 
diffuse type of SSc is enrolled in the present study, 
which may differ from the overall distribution of SSc 
types. Also, controls included in the present study are 
recruited from the generaldental outpatient office and, 
although matched for age and sex, may therefore not 
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Table 4. 
Linear Associations of SSc and lndividuals' Characteristics With Mean AL 
Chcra:teriS:ics 
ffi: 
No 
Yes 
Type of ffi: 
No 
Diffu~ ffi: 
Umited ffi: 
~ 
Fernales 
Males 
Aga (per 1 yecr) 
8:lucctional cttanment 
None 
Traned worker 
Acedernie 
Snoking S:cius 
Never gnoker 
FOrmer gnoker 
Current gnoker 
Alcohol conSJmption frequency 
831dom 
Moderciely often 
Daly 
BMI (kg'm2) 
<25 
25 to 30 
>30 
Cl = confidence interval. 
Table 5. 
AL (mm) (95% Cl) 
(referenre) 
0.61 (0.24 to 0.97) 
(referenre) 
0.81 (0.39 to 1.22) 
0.29 ( -0.29 to 0.87) 
(referenre) 
0.43 (-0.04 to 0.89) 
0.015 (0.00 to 0.29) 
(referenre) 
-0.71 ( -1.32 to -0.11) 
-0.63 (-1.27 to 0.003) 
(referenre) 
0.06 ( -0.37 to 0.49) 
0.08 (-0.48 to 0.64) 
(referenre) 
-0.37 (-0.78 to 0.04) 
0.43 (-0.24 to 1.01) 
(referenre) 
0.20 ( -0.22 to 0.62) 
-0.00 ( -0.69 to 0.68) 
p 
0.002 
<0.001 
0.32 
0.07 
0.04 
0.02 
0.05 
0.77 
0.78 
0.08 
0.21 
0.36 
0.99 
Acljusted AL (95% CI) of Patients With SSc Compared With Control Individuals With and 
Without Acljustment to Oral Hygiene Indices (PI and GI) 
AdjuS:ment for AL (mm) for the ASEDdciion of 
Model A GI ffi: With A3riodontitis (95% Cl) p 
1* No No 0.52 (0.16 to 0.88) 0.005 
2t Yes No 0.44 (0.24 to 0.86) 0.04 
3t No Yes 0.61 (0.24 to 0.97) 0.001 
4t Yes Yes 0.64 (0.21 to 1.08) 0.004 
• Model 1 included SSc status, age, and sex as independent variables and mean AL as the dependent variable. 
t Models 2 to 4 include SSc status, age, and sex, as weil as PI, GI, or both as independent variables and periodontitis as a dependent variable. 
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be representative for the general population. However, 
it is expected that the relationship between SSc and 
periodontitis found in this study should be similar to 
mal es and females in general, although the strength of 
this association and the extent to what degree this 
association could be explained by oral hygiene may 
vary according to the extent of oral hygiene, dental 
problems, and the underlying general population. The 
sample size of this study is relatively small, and 
confidence intervals are relatively !arge, which Iimits 
the precision of the estimates. Thus, although they are 
statistically significant, the point estimates found in 
this study have tobe interpreted cautiously. Therefore, 
future studies with !arger numbers of individuals and 
prospective design are warranted to examine the 
association of SSc with periodontitis in more detail. 
CONCLUSION 
The present study shows that patients with SSc, al-
though showing fewer signs of periodontal BOP and 
gingival inflammation, have an increased AL compared 
with healthy individuals, which stayed significant after 
adjustment for known risk factors of periodontitis. 
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